{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:19:09Z","timestamp":1789809549566,"version":"4.0.1"},"reference-count":24,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2004,2,1]],"date-time":"2004-02-01T00:00:00Z","timestamp":1075593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Toxicol Pathol"],"published-print":{"date-parts":[[2004,2]]},"abstract":"<jats:p>As part of the international evaluation program coordinated by ILSI\/HESI, the potential of DNA repair deficient Xpa- \/- mice and the double knockout Xpa- \/- .p53+ \/- mice for short term carcinogenicity assays was evaluated. For comparison also wild-type C57BL\/6 mice (WT) were included in these studies. Four test compounds were administered to groups of 15 male and 15 female Xpa- \/- mice, Xpa- \/- .p53+ \/- mice and WT mice for 39 weeks. The model compounds investigated were haloperidol, reserpine (nongenotoxic rodent carcinogens, putative human noncarcinogens), phenacetin (genotoxic rodent carcinogen, suspected human carcinogen), and D-mannitol (noncarcinogen in rodents and humans). The test compounds were administered as admixture to rodent diet at levels up to 25 mg\/kg diet for haloperidol, 7.5 mg\/kg diet for reserpine, 0.75% for phenacetin, and 10% for D-mannitol. These levels included the maximum tolerable dose (MTD). Survival was not affected with any of the test compounds. Haloperidol, reserpine and D-mannitol were negative in the carcinogenicity assay with Xpa- \/- and Xpa- \/- .p53+ \/- mice, showing low and comparable tumor incidences in controls and high-dose animals. The results obtained with phenacetin may be designated equivocal in Xpa- \/- .p53+ \/- mice, based on the occurrence of a single rare tumor in the target organ (kidney) accompanied by a low incidence of hyperplastic renal lesions and a high incidence of karyomegaly. These results are in agreement with the currently known carcinogenic potential of the 4 test compounds in humans.<\/jats:p>","DOI":"10.1080\/01926230490274344","type":"journal-article","created":{"date-parts":[[2004,4,12]],"date-time":"2004-04-12T11:45:11Z","timestamp":1081770311000},"page":"192-201","source":"Crossref","is-referenced-by-count":9,"title":["Evaluation of the Xpa-Deficient Transgenic Mouse Model for Short-Term Carcinogenicity Testing: 9-Month Studies with Haloperidol, Reserpine, Phenacetin, and D-Mannitol"],"prefix":"10.1177","volume":"32","author":[{"given":"Ben A.R.","family":"Lina","sequence":"first","affiliation":[{"name":"TNO Nutrition and Food Research, Zeist, The Netherlands,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruud A.","family":"Woutersen","sequence":"additional","affiliation":[{"name":"TNO Nutrition and Food Research, Zeist, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joost P.","family":"Bruijntjes","sequence":"additional","affiliation":[{"name":"TNO Nutrition and Food Research, Zeist, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Van Benthem","sequence":"additional","affiliation":[{"name":"National Institute of Public Health and the Environment, Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanda A.H.","family":"Van Den Berg","sequence":"additional","affiliation":[{"name":"National Institute of Public Health and the Environment, Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Monbaliu","sequence":"additional","affiliation":[{"name":"Janssen Pharmaceutica N.V., Beerse, Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob J.J.M.","family":"Thoolen","sequence":"additional","affiliation":[{"name":"Solvay Pharmaceuticals B.V., Weesp, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf B.","family":"Beems","sequence":"additional","affiliation":[{"name":"National Institute of Public Health and the Environment, Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen F.","family":"Van Kreijl","sequence":"additional","affiliation":[{"name":"National Institute of Public Health and the Environment, Bilthoven, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2004,2,1]]},"reference":[{"key":"atypb1","doi-asserted-by":"publisher","DOI":"10.1016\/S0940-2993(11)80259-9"},{"key":"atypb2","first-page":"581","volume":"57","author":"Berg, R.J.W.","year":"1997","journal-title":"Cancer Res"},{"key":"atypb3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2744(199705)19:1<46::AID-MC7>3.0.CO;2-L"},{"key":"atypb4","doi-asserted-by":"publisher","DOI":"10.1038\/377169a0"},{"key":"atypb5","first-page":"211","volume":"24","year":"1980","journal-title":"IARC Monographs"},{"key":"atypb6","first-page":"310","volume":"7","year":"1987","journal-title":"IARC Monographs Supplement"},{"key":"atypb7","doi-asserted-by":"publisher","DOI":"10.1006\/rtph.1996.0108"},{"key":"atypb8","doi-asserted-by":"publisher","DOI":"10.1080\/019262302753559524"},{"key":"atypb9","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.2910290413"},{"key":"atypb10","volume-title":"National Toxicology Program. Bioassay of reserpine for possible carcinogenicity","author":"NTP","year":"1980"},{"key":"atypb11","unstructured":"NTP Working group (1982). Carcinogenesis bioassay of D-mannitol in F344\/N rats and B6C3F1 mice. National Toxicology Program Technical Report Series 236, 158 p."},{"key":"atypb12","doi-asserted-by":"publisher","DOI":"10.1080\/019262301753178447"},{"key":"atypb13","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.5778"},{"key":"atypb14","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600402"},{"key":"atypb15","doi-asserted-by":"publisher","DOI":"10.1080\/019262301753178438"},{"key":"atypb16","doi-asserted-by":"publisher","DOI":"10.1080\/019262301753178465"},{"key":"atypb17","doi-asserted-by":"publisher","DOI":"10.1289\/ehp.95103942"},{"key":"atypb18","first-page":"280","volume":"29","author":"Van Benthem, J.","year":"2001","journal-title":"Toxicologic Pathology"},{"key":"atypb19","doi-asserted-by":"publisher","DOI":"10.1080\/019262301753178528"},{"key":"atypb20","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600607"},{"key":"atypb21","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2280(1999)34:2\/3<124::AID-EM11>3.0.CO;2-F"},{"key":"atypb22","doi-asserted-by":"publisher","DOI":"10.1080\/019262301753178519"},{"key":"atypb23","doi-asserted-by":"publisher","DOI":"10.1177\/019262339802600605"},{"key":"atypb24","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/17.11.2455"}],"container-title":["Toxicologic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/01926230490274344","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1080\/01926230490274344","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:29:10Z","timestamp":1777620550000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1080\/01926230490274344"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2004,2]]}},"alternative-id":["10.1080\/01926230490274344"],"URL":"https:\/\/doi.org\/10.1080\/01926230490274344","relation":{},"ISSN":["0192-6233","1533-1601"],"issn-type":[{"value":"0192-6233","type":"print"},{"value":"1533-1601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,2]]}}}